Indija - engleski - Central Drugs Standard Control Organization

unimed - hydroxyzine hcl.,ephedrine hcl.,theophylline - cap - 10,25,130;mg - 20

Nigerija - engleski - NAFDAC (National Agency for Food and Drugs Administration and Control)

anhydrous theophylline 130mg, ephedrine s04 25mg, hydroxyzine dihydrochloride 10mg

Nigerija - engleski - NAFDAC (National Agency for Food and Drugs Administration and Control)

ephedrine sulphate hydroxyzine dihydrochloride 2.5mg, anhydrous theophylline 32.5mg

Nigerija - engleski - NAFDAC (National Agency for Food and Drugs Administration and Control)

hydroxyzine 25mg. theophylline 130mg

Armenija - engleski - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merck sharp & dohme corp.13900 north west 57th court - ceftibuten - capsules hard - 400mg

Armenija - engleski - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merck sharp & dohme corp.13900 north west 57th court - ceftibuten - powder for oral suspension - 36mg/ml

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 48 mg/ml - oral liquid, solution - excipient ingredients: benzoic acid; hydrochloric acid; purified water; potassium sorbate; allura red ac; glycerol; macrogol 1500; propylene glycol; saccharin sodium; sorbitol solution (70 per cent) (non-crystallising); flavour - for the relief of pain and fever.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 24 mg/ml - oral liquid, solution - excipient ingredients: glycerol; macrogol 1500; ponceau sx; saccharin sodium; propylene glycol; purified water; benzoic acid; potassium sorbate; flavour; maltitol solution - relief of pain and fever in children.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - posaconazole, quantity: 40 mg/ml - oral liquid, suspension - excipient ingredients: sodium benzoate; sodium citrate dihydrate; citric acid monohydrate; titanium dioxide; glycerol; xanthan gum; liquid glucose; peg-40 hydrogenated castor oil; purified water; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid; flavour - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: ? treatment of oropharyngeal candidiasis in immunocompromised adults, including patients with disease that is refractory to itraconazole and fluconazole. ? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

uriel pharmacy inc. - taraxacum palustre root (unii: gcz4w7077c) (taraxacum palustre root - unii:gcz4w7077c) - taraxacum palustre root 2 [hp_x] in 1 ml - directions: for oral use only. use: temporary relief of digestive upset.